fda semaglutide news The obesity drug (Wegovy) conferred a significantly higher risk of ischemic optic neuropathy (ION) than any other GLP-1 agonist, including semaglutide for diabetes (Ozempic), an analysis of data showed. Added FDA Warns on Certain Forms

Quick Stats, USA Weight Management Beverages USA Weight Management Beverages Sales Value (2025): $1.65 billion USA Weight Management Beverages Forecast Value (2035): $3.37 billion USA Weight Management Beverages Forecast CAGR: 7.4% Leading Product Category in USA Weight Management Beverages Industry: Protein-based RTD (47%) Source: Fact.MR (November 2025) He also points out a growing consumer acceptance of different organoleptic characteristics in their beverages

Furue 2020)

Different transaminases recognize different amino acids, but they all use -ketoglutarate and glutamate as one -keto acid/-amino acid pair

Alternating between the abdomen and thigh each week is a simple, effective rotation strategy that prevents irritation and lipohypertrophy